Archive - July 2019
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults
Acacia Pharma Plans to Resubmit the Barhemsys NDA in Q3 2019
NHS improvements can’t happen ‘overnight’, says NHS Confederation
GSK’s Dovato hits endpoints in late-stage study
Amazon’s Alexa to offer NHS healthcare advice
Pharma industry invests £377m in UK R&D collabs
Healthcare regulators to gain autonomy